ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    Early Considerations for Deceased Donor Chains

    A. Toll,1 R. Leishman,1 V. Casingal,2 M. Aeder,3 T. Sandholm,4 N. Turgeon.5

    1UNOS, Richmond, VA; 2Carolinas HeathCare Sys, Charlotte, NC; 3Univ Hosp Med Ctr, Cleveland, OH; 4Carnegie Mellon Univ, Pittsburgh, PA; 5Emory Univ, Atlanta, GA.

    Background: The potential use of deceased kidney donors (DDs) to initiate kidney paired donation (KPD) chains (DD chains) has been of interest to the transplant…
  • 2018 American Transplant Congress

    A Novel Peripheral Blood mRNA Biomarker Predicts Subclinical Rejection and Kidney Transplant Outcomes

    J. Friedewald,1 S. Kurian,2 T. Whisenant,2 R. Heilman,3 E. Poggio,4 C. Marsh,2 P. Baliga,5 N. Bridges,6 J. Odim,6 M. Brown,6 D. Ikle,7 B. Armstrong,7 J. Charette,1 S. Brietigam,1 N. Sustento-Reodica,1 L. Zhao,1 M. Kandpal,1 D. Salomon,2 M. Abecassis.1

    1Northwestern Medicine, Chicago; 2Scripps, La Jolla; 3Mayo AZ, Scottsdale; 4Cleveland Clinic, Cleveland; 5MUSC, Charleston; 6NIAID, Bethesda; 7Rho, Chapel Hill.

    BACKGROUNDSub-clinical acute rejection (subAR) in kidney transplant recipients (KTR), defined as histological rejection on surveillance biopsy (Bx) in a patient with stable renal function, signals…
  • 2018 American Transplant Congress

    Dialysis Modality, Inflammation, and Frailty in Kidney Transplant Candidates

    P. Shrestha, H. Ying, M. McAdams DeMarco, D. Segev.

    JHU, Baltimore, MD.

    Inflammation is associated with poor physical performance, frailty, disability and death in community-dwelling older adults. Given the elevated inflammation levels among ESRD patients, it is…
  • 2018 American Transplant Congress

    Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study

    S. Mulgaonkar,1 J. Pascual,1 S. Chadban,1 H. Tedesco,1 S. Berger,1 Y. Qazi,1 C. Legendre,1 N. Basic-Jukic,1 P. Bernhardt,2 F. Vincenti.1

    1TRANSFORM Study Group, Livingston; 2Novartis Pharma AG, Basel, Switzerland.

    Purpose: Everolimus (EVR)-facilitated calcineurin inhibitor (CNI) reduction regimens help prevent long-term CNI nephrotoxicity in kidney transplant recipients (KTxRs). TRANSFORM (NCT01950819) is the largest study in…
  • 2018 American Transplant Congress

    Validation Study of Operational Tolerance Signatures in Korean Kidney Transplantation Recipients

    J. Seo,1 Y. Lee,1 Y. Kim,1 J. Moon,1 K-.H. Jeong,1 C-.D. Kim,2 J. Park,3 B. Jeong,4 S-.H. Lee.1

    1Department of Nephrology, School of Medicine, Kyung Hee University, Seoul, Korea; 2Department of Nephrology, Kyung-pook National University School of Medicine, Daegu, Korea; 3Department of Nephrology, Sungkyunkwan University, Samsung Hospital, College of Medicine, Seoul, Korea; 4Department of Nephrology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

    Background:A peripheral B cell population was significantly higher in drug-free operationally tolerant patients than those with stable graft function or acute rejection under standard immunosuppression.…
  • 2018 American Transplant Congress

    Donor-Derived Cell-Free DNA Outperforms Serum Creatinine Changes for Identifying Kidney Transplant Rejection

    M. Weir,1 D. Hiller,2 J. Yee,2 A. Matas.3

    1University of Maryland School of Medicine, Baltimore, MD; 2CareDx, Brisbane, CA; 3University of Minnesota School of Medicine, Minneapolis, MN.

    Purpose: In the DART study, donor-derived cell-free DNA (dd-cfDNA) discriminated biopsy-based diagnosis of active rejection in kidney transplant patients but serum creatinine (sCr) level did…
  • 2018 American Transplant Congress

    Biopsy Correlates of DSA in Antibody-Mediated Rejection: C4d vs Microvascular Inflammation Scores

    C. Harris, L. Anderson, R. Khaim, J. Choudhuri, R. Shapiro, S. Florman, F. Salem, M. Menon.

    Icahn School of Medicine at Mount Sinai, New York, NY.

    Background: The diagnosis of antibody-mediated rejection (AMR) requires the presence of both the histologic features of AMR as well as donor-specific antibodies (DSA). Whether anti-HLA…
  • 2018 American Transplant Congress

    A Substantial Fraction of Surveillance Transplant Biopsies Have Clinically Actionable Findings

    A. Shammout,1 A. Naik,2 M. Samaniego,2 E. Farkash.1

    1Pathology, Michigan Medicine, Ann Arbor; 2Nephrology, Michigan Medicine, Ann Arbor.

    Background: Surveillance biopsies in renal transplant recipients may detect subclinical disease that affects graft longevity. At our transplant center, most patients with stable allograft function…
  • 2018 American Transplant Congress

    Gains from Joining Kidney Paired Donation with Several Incompatible Donors

    M. Bray, W. Wang, P. Song, J. Kalbfleisch.

    University of Michigan, Ann Arbor, MI.

    In kidney paired donation (KPD), a transplant candidate with an incompatible donor joins a pool of similar pairs in an effort to find new transplant…
  • 2018 American Transplant Congress

    Do We Need to Worry about EBV DNAemia in the Late Post-Transplant Period?

    M. Morton,1 K. Daga,2 P. Klapper,2 M. Picton,1 P. Vallely.2

    1Department of Renal Medicine, Manchester Royal Infirmary, Manchester, United Kingdom; 2University of Manchester, Manchester, United Kingdom.

    Background: Despite detectable Epstein-Barr virus (EBV) in blood, kidney transplant patients (KTR) may have no apparent clinical consequence. This study aims to explore the clinical…
  • « Previous Page
  • 1
  • …
  • 312
  • 313
  • 314
  • 315
  • 316
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences